Literature DB >> 33910859

Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.

Masamichi Hayashi1, Suguru Yamada2, Nao Takano1, Yukiyasu Okamura3, Hideki Takami1, Yoshikuni Inokawa1, Fuminori Sonohara1, Nobutake Tanaka1, Dai Shimizu1, Norifumi Hattori1, Mitsuro Kanda1, Chie Tanaka1, Goro Nakayama1, Masahiko Koike1, Yasuhiro Kodera1.   

Abstract

BACKGROUND/AIM: Hepatocellular carcinoma (HCC) mainly develops in the damaged liver from hepatitis C virus (HCV) or hepatitis B virus (HBV) infection in Japan. On the other hand, the occurrence of HCCs derived from the liver without viral infection has recently been increasing. Our aim was to identify characteristics specific to HCCs with virus-infected liver (HCC-BC) or those with non-B- and non-C-infected liver (HCC-NBNC), Patients and
Methods: We collected preoperative serum α-fetoprotein (AFP) and Des-Gamma-Carboxy Prothrombin (DCP), also known as PIVKA-II values from surgically resected HCC cases during 1994-2017 in our department.
RESULTS: Preoperative serum AFP values of HCC-BC cases (n=284) were higher compared to HCC-NBNC cases (n=88) (p=0.016), whereas serum DCP values of HCC-NBNC cases were higher compared to HCC-BC cases (p<0.001). Multivariable analyses indicated that abnormal serum AFP [hazard ratio (HR)=1.46, 95% conficdence interval (CI)=1.03-2.07, p=0.035) was one of the significant recurrence-free survival predictors of HCC-BC cases, while abnormal serum DCP (HR=4.99, 95%CI=1.91-13.01, p=0.001) was one of the significant recurrence-free survival predictors of HCC-NBNC cases.
CONCLUSION: HCC-NBNC cases have a different tumor marker profile from HCC-BC cases. Elevated DCP could be both a diagnostic and prognostic marker of HCC-NBNC patients. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  AFP; DCP; hepatocellular carcinoma; survival predictor

Mesh:

Substances:

Year:  2021        PMID: 33910859      PMCID: PMC8193278          DOI: 10.21873/invivo.12434

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  27 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.

Authors:  Maissa El Raziky; Dina Attia; Wafaa El Akel; Olfat Shaker; Hany Khatab; Shaimaa Abdo; Aisha Elsharkawy; Gamal Esmat
Journal:  Arab J Gastroenterol       Date:  2013-10-10       Impact factor: 2.076

3.  Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.

Authors:  Hideto Suzuki; Kazumoto Murata; Takaya Gotoh; Masao Kusano; Hiroshi Okano; Takashi Oyamada; Yoshikazu Yasuda; Masatoshi Imamura; Masatoshi Kudo; Masashi Mizokami; Atsushi Sakamoto
Journal:  J Gastroenterol       Date:  2011-07-09       Impact factor: 7.527

Review 4.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

5.  Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.

Authors:  Tatsuya Taniguchi; Kazuhiro Kishi; Tadahiko Nakagawa; Hironori Tanaka; Takahiro Tanaka; Tetsu Tomonari; Koichi Okamoto; Masahiro Sogabe; Hiroshi Miyamoto; Toshiya Okahisa; Naoki Muguruma; Mayumi Kajimoto; Ikuko Sagawa; Tetsuji Takayama
Journal:  Digestion       Date:  2017-04-07       Impact factor: 3.216

6.  Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.

Authors:  J C Edman; P Gray; P Valenzuela; L B Rall; W J Rutter
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

7.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Authors:  Kornelius Schulze; Sandrine Imbeaud; Eric Letouzé; Ludmil B Alexandrov; Julien Calderaro; Sandra Rebouissou; Gabrielle Couchy; Clément Meiller; Jayendra Shinde; Frederic Soysouvanh; Anna-Line Calatayud; Roser Pinyol; Laura Pelletier; Charles Balabaud; Alexis Laurent; Jean-Frederic Blanc; Vincenzo Mazzaferro; Fabien Calvo; Augusto Villanueva; Jean-Charles Nault; Paulette Bioulac-Sage; Michael R Stratton; Josep M Llovet; Jessica Zucman-Rossi
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

8.  Arid1a regulates insulin sensitivity and lipid metabolism.

Authors:  Yu-Lan Qu; Chuan-Huai Deng; Qing Luo; Xue-Ying Shang; Jiao-Xiang Wu; Yi Shi; Lan Wang; Ze-Guang Han
Journal:  EBioMedicine       Date:  2019-03-14       Impact factor: 8.143

9.  Somatic mutations and clonal dynamics in healthy and cirrhotic human liver.

Authors:  Simon F Brunner; Nicola D Roberts; Luke A Wylie; Luiza Moore; Sarah J Aitken; Susan E Davies; Mathijs A Sanders; Pete Ellis; Chris Alder; Yvette Hooks; Federico Abascal; Michael R Stratton; Inigo Martincorena; Matthew Hoare; Peter J Campbell
Journal:  Nature       Date:  2019-10-23       Impact factor: 49.962

10.  Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.

Authors:  Ting Song; Lili Wang; Ruopei Xin; Liping Zhang; Yun Tian
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.